Purified anti-VEGF Antibody anti-VEGF - Poly6275,BioLegend,627501

This product may contain other non-IgG subtypes.

Host

Rabbit

Reactivity

Human

Application

WB - Quality tested

Platform ID

BAB715835758

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-VEGF Antibody anti-VEGF - Poly6275
Cat. No.627501
HostRabbit
RRIDAB_2272658 (BioLegend Cat. No. 627501)
IsotypeRabbit Polyclonal IgG
ReactivityHuman
ApplicationWB - Quality tested
ClonalityPolyclonal
Clone NumberPoly6275
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetVEGF
ImmunogenPeptide mapping to a domain near the N-terminus
PurityThe antibody was purified by antigen-affinity chromatography.
FormulationThis antibody is provided in phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% gelatin.Previous lots of this product may have been formulated with 0.1% or 0.05% NaN3instead of 0.09% NaN3. For further information please contact BioLegendTechnical SupportorCustomer Service.
StorageUpon receipt, store undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

VEGF, also known as vascular endothelial growth factor, vasculotropin, and vascular permeability factor, is a widely expressed mitogen for vascular endothelial cells that has been shown to promote angiogenesis and increase permeability of capillary blood vessels. VEGF is a member of the platelet-derived growth factor (PDGF) family and is produced as a homodimeric protein with approximate molecular weights of 34-46 kD. The variance in molecular weight is a result of alternative splicing events that encode monomeric proteins having 121, 165, 189 or 206 amino acids. VEGF121 and VEGF165 are secreted proteins whereas VEGF189 and VEGF206 are strongly cell-associated. VEGF binds to VEGF-R1 (also known as Flt-1) and VEGF-R2 (also known as KDR). Inhibition of VEGF biding to VEGF-Rs has been the focus of a number of tumor therapeutic strategies. The Poly6275 antibody recognizes the N-terminal region of human VEGF has been shown to be useful for Western blotting of both reduced and non-reduced VEGF.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.